Document is current
Any future updates will be listed below
-
Authors
Pablo, Luis
Garay-Aramburu, Gonzaga https://orcid.org/0000-0001-5255-8426
García Layana, Alfredo
Fernandez, Anxo
Vázquez, Inmaculada
Acebes, Xenia
Zulueta, Jacinto
Balonga, Delfina
Salinas-Ortega, Laura https://orcid.org/0000-0002-7066-0659
Muñoz, Álvaro https://orcid.org/0000-0003-0896-1423
Casado Gómez, Araceli https://orcid.org/0000-0003-0201-7247
Casado, Miguel Ángel https://orcid.org/0000-0002-8743-6653
Salvador, Julia
Bañón-Rodriguez, Inmaculada
Ruíz-Moreno, José María https://orcid.org/0000-0001-9636-0788
- License Information
-
More Information
Article History
Received: 14 December 2022
Accepted: 7 August 2024
First Online: 3 September 2024
Declarations
:
: Not applicable
: All the authors approved the final version of the manuscript.
: LP, AGL, AF, JZ and JMRM have received payments for the participation in advisory meetings for this project. No honoraria or payments were made for authorship or for any activity related to the publication development.GGA has received a publication grant from Allergan and has received payments for the participation in advisory meetings for this project. No honoraria or payments were made for authorship or for any activity related to the publication development.JS was a paid employee of AbbVie during the development of the present work, and IBR is a paid employee of AbbVie and might have stock ownership or options. LSO, ACG and MAC are employees of Pharmacoeconomics & Outcomes Research Iberia (PORIB) a consultant company specialized in health technology assessment, which has received financial support from AbbVie to conduct the development of the present work. AMC was a paid employee of PORIB during the development of the present work.IV, DB and XA have not received any payment for the development of this project and have no competing interests.
